Control Bionics Ltd
Control Bionics Limited, together with its subsidiaries, engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia, North America, and internationally. It offers NeuroNode Trilogy, NeuroNode Duo, and Eye-gaze Duo systems that allow people with speech and movement difficulties to control a computer for speech generation, electroni… Read more
Control Bionics Ltd (CBL) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: -0.288x
Based on the latest financial reports, Control Bionics Ltd (CBL) has a cash flow conversion efficiency ratio of -0.288x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.22 Million) by net assets (AU$7.73 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Control Bionics Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Control Bionics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Control Bionics Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Control Bionics Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ramlosa Shipping Ab
ST:RAMSH
|
N/A |
|
Pixon Technologies Corporation
TWO:5248
|
0.077x |
|
Shinkin Central Bank
PINK:SKCBY
|
0.003x |
|
Bioscience Animal Health PCL
BK:BIS
|
0.126x |
|
EMC Public Company Limited
BK:EMC
|
-0.017x |
|
A-Smart Holdings Ltd.
F:IOTA
|
N/A |
|
Great Divide Mining Ltd
AU:GDM
|
-0.092x |
|
The Western India Plywoods Limited
NSE:WIPL
|
0.093x |
Annual Cash Flow Conversion Efficiency for Control Bionics Ltd (2017–2024)
The table below shows the annual cash flow conversion efficiency of Control Bionics Ltd from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | AU$5.51 Million | AU$-4.27 Million | -0.775x | +1.11% |
| 2023-12-31 | AU$6.27 Million | AU$-4.91 Million | -0.784x | -23.18% |
| 2022-12-31 | AU$7.12 Million | AU$-4.53 Million | -0.636x | -10.15% |
| 2021-12-31 | AU$11.92 Million | AU$-6.89 Million | -0.578x | -148.41% |
| 2020-12-31 | AU$17.16 Million | AU$-3.99 Million | -0.233x | -441.59% |
| 2019-12-31 | AU$20.13 Million | AU$-864.05K | -0.043x | +88.85% |
| 2018-12-31 | AU$5.05 Million | AU$-1.95 Million | -0.385x | -141.49% |
| 2017-12-31 | AU$6.09 Million | AU$-970.84K | -0.159x | -- |